March 18, 2014 | Forbes.com
In testimony last week before the Senate Health, Education, Labor and Pensions Committee during a hearing about the agency's current initiatives, FDA Commissioner Margaret Hamburg spoke about the pending application for approval of a genetically engineered Atlantic salmon. "We will be moving forward in a deliberate, science-driven way, reflecting all of the important inputs ... as we consider this product application," Hamburg testified to the committee. That’s disingenuous, and she knows it. What she left unsaid is that only one “input” counts: the White House’s undue influence over the FDA’s review.